Apellis Pharmaceuticals, Inc.
APLS
50 insider filings · Latest: May 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | Jan 13 11:00 PM | Deschatelets Pascal | Proposed Sale | 2,331 | $28.70 | $66.9K | — | View → |
| Jan 13, 2025 | Jan 13 10:56 PM | DeLong Mark Jeffrey | Proposed Sale | 1,627 | $28.70 | $46.7K | — | View → |
| Jan 13, 2025 | Jan 13 10:55 PM | Chopas James George | Proposed Sale | 798 | $28.70 | $22.9K | — | View → |
| Jan 6, 2025 | Jan 6 8:17 PM | Baumal Caroline | Proposed Sale | 2,816 | $33.81 | $95.2K | — | View → |
| Dec 23, 2024 | Dec 23 8:09 PM | Eisele Jeffrey | Proposed Sale | 63 | $33.09 | $2.1K | — | View → |
| Dec 11, 2024 | Dec 11 9:48 PM | DAVID OSBORNE WATSON | Proposed Sale | 5,000 | $34.24 | $171.2K | — | View → |
| Sep 16, 2024 | Sep 16 7:22 PM | Chopas James George | Proposed Sale | 192 | $36.21 | $7.0K | — | View → |
| Sep 3, 2024 | Sep 3 7:16 PM | Chopas James George | Proposed Sale | 550 | $39.49 | $21.7K | — | View → |
← Previous
Page 6 of 6
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | May 14 11:37 PM | Sinclair A. DunlopDirector | Disposition | 102,826 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:34 PM | James George ChopasVP/Chief Accounting Officer | Disposition | 81,053 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:34 PM | Mikael DolstenDirector | Disposition | 24,135 | $20.96 | 0(D) | View → |
| May 14, 2026 | May 14 11:32 PM | Leslie MeltzerChief Research and Development | Disposition | 92,592 | $27.93 | 0(D) | View → |
| May 14, 2026 | May 14 11:31 PM | Paul R. FonteyneDirector | Disposition | 112,726 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:30 PM | Timothy Eugene SullivanChief Financial Officer | Disposition | 677,390 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:29 PM | Alec MachielsDirector | Disposition | 242,300 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:27 PM | Pascal DeschateletsChief Scientific Officer | Disposition | 588,996 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:26 PM | Gerald ChanDirector | Disposition | 242,300 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:25 PM | Nur NicholsonChief Technical Officer | Disposition | 357,594 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:24 PM | Keli WalbertDirector | Disposition | 30,072 | $33.00 | 0(D) | View → |
| May 14, 2026 | May 14 11:23 PM | Mark Jeffrey DelongChief Business & Strat Officer | Disposition | 235,736 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:22 PM | Stephanie Monaghan O'BrienDirector | Disposition | 242,300 | $59.86 | 0(D) | View → |
| May 14, 2026 | May 14 11:20 PM | Kelley BoucherChief People Officer | Disposition | 146,138 | $28.17 | 0(D) | View → |
| May 14, 2026 | May 14 11:19 PM | Craig A WheelerDirector | Disposition | 42,879 | $25.12 | 0(D) | View → |
| May 14, 2026 | May 14 11:19 PM | David O. WatsonGeneral Counsel | Disposition | 302,965 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:17 PM | Cedric FrancoisDirector, Chief Executive Officer | Disposition | 1,697,706 | $66.30 | 0(D) | View → |
| May 14, 2026 | May 14 11:16 PM | Caroline BaumalChief Medical Officer | Disposition | 168,500 | $66.30 | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:06 PM | Mikael DolstenDirector | Grant/Award | 24,135 | $20.96 | 24,135(D) | View → |
| Feb 3, 2026 | Feb 5 9:14 PM | Cedric FrancoisDirector, Chief Executive Officer | Option Exercise | 8,840 | $3.76 | 0(D) | View → |